Copper homeostasis and neurodegenerative disorders (Alzheimer's, prion, and Parkinson's diseases and amyotrophic lateral sclerosis).
By E. Gaggelli, H. Kozłowski, D. Valensin, G. Valensin. Chemical Reviews, 2006
1,622 citations recorded by the source corpus.
Subfields: Molecular Biology, Nutrition and Dietetics, Physiology
View Paper: https://www.semanticscholar.org/paper/cbcdf854c4a3a9d6688906a63f6f63b394db7b33
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Molecular Biology
Citations in the corpus
- Copper in diseases and treatments, and copper‐based anticancer strategies (2009, background): “Copper has also been reported to play a role in the pathogenesis of neurodegenerative diseases, including amyotrophic lateral sclerosis (ALS), AD, and the prion-mediated encephalopathies.(93) Genetic disorders of the proteins involved in the copper machinery have long been known, and related disease”
- Copper induces cell death by targeting lipoylated TCA cycle proteins (2022, background): “Genetic variation in copper homeostasis results in life-threatening disease (39, 40), and both copper ionophores (11, 17, 41, 42) and copper chelators (43–46) have been suggested as anticancer agents.”